Will Date - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Will Date's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Will Date
Verified
Editor, Cardiovascular News
London
Beats
Biography
Will studied for a degree in Journalism and Media Studies at the University of Portsmouth. He has worked at publications including the Leighton Buzzard Observer, The Luton News and Dunstable Gazette as well as a brief stint at the New Indian Express in Chennai, South India. Will is an ardent supporter of Liverpool Football Club.
health, creativity and nature,Wellbeing travel, fitness
PR
Content
By Will Date Verified| Vascular Specialist Online Verified Merit Medical Systems has announced that the six-month results from the randomized arm of the Wrapsody arteriovenous access efficacy—WAVE—trial are scheduled for publication in the April issue of Kidney International, ahead of the presentation of 12-month results from the trial at the Society of Interventional Radiology’s 50th annual scientific meeting (March 29–April 2) in Nashville, Tennessee.
Stereotaxis seeks to broaden use of its robotic magnetic navigation system into multiple endovascular fields
By Will Date Verified| Vascular Specialist Online Verified Stereotaxis has announced a Food and Drug Administration (FDA) regulatory submission for the first robotically navigated catheter designed to expand usage of robotic magnetic navigation into the broader endovascular field. Emagin 5F is the first in a family of robotically navigated endovascular devices being developed by Stereotaxis. The Emagin brand—short for Endovascular Magnetic Intervention—will encompass a portfolio of robotic catheters and wires.
By Will Date Verified| Vascular Specialist Online Verified Merit Medical Systems has announced that the six-month results from the randomized arm of the Wrapsody arteriovenous access efficacy—WAVE—trial are scheduled for publication in the April issue of Kidney International, ahead of the presentation of 12-month results from the trial at the Society of Interventional Radiology’s 50th annual scientific meeting (March 29–April 2) in Nashville, Tennessee.
Company Info
Cardiovascular News
Cardiovascular News is an international newspaper dedicated to providing reliable news and insights for cardiovascular specialists. It covers a wide range of topics in cardiovascular health, including advancements in treatments, technologies, and research findings. The publication offers in-depth news updates on clinical trials, new medical devices, and innovative treatments. It also features expert opinions and analyses from leading figures in the field, helping professionals understand current challenges and future directions. Additionally, Cardiovascular News covers educational events, such as conferences and workshops, to keep healthcare professionals informed about best practices and emerging techniques. Targeting cardiovascular specialists, researchers, and healthcare professionals, Cardiovascular News serves as a vital resource for those looking to stay updated on the latest developments in cardiovascular medicine.
London, United Kingdom
Founded: 2010